documents: FDA-1978-N-2157-0003
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1978-N-2157-0003 | FDA | FDA-1978-N-2157 | Internal Memorandum from Director Division of OTC Drug Evaluation (HFN-810) to Dockets Management Branch (HFA-305) | Other | Memorandum | 2004-02-02T05:00:00Z | 2004 | 2 | 2019-06-05T13:39:26Z | 0 | 0 | 09000064805a6712 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref